Monika Krampert

Title: Monika Krampert: Innovator in Therapeutic Compositions

Introduction

Monika Krampert is a distinguished inventor based in Bamberg, Germany. She has made significant contributions to the field of therapeutic compositions, holding a total of five patents. Her work focuses on innovative solutions that target critical biological processes.

Latest Patents

Among her latest patents is the invention titled "HNF4a saRNA compositions and methods of use." This invention relates to saRNA targeting an HNF4a transcript and includes therapeutic compositions comprising said saRNA. Additionally, she has developed a patent for "Antisense-oligonucleotides as inhibitors of TGF-R signaling." This invention involves antisense-oligonucleotides with a length of at least 10 nucleotides, where at least two of the nucleotides are LNAs. These oligonucleotides serve as inhibitors of TGF-R signaling and are intended for the prophylaxis and treatment of various diseases, including neurological, neurodegenerative, fibrotic, and hyperproliferative conditions.

Career Highlights

Monika has worked with notable companies such as Mina Therapeutics Limited and Neurovision Pharma GmbH. Her career reflects a commitment to advancing therapeutic technologies and improving patient outcomes through innovative research.

Collaborations

Throughout her career, Monika has collaborated with esteemed colleagues, including Markus Hossbach and Hans E Huber. These partnerships have contributed to her success and the development of her groundbreaking inventions.

Conclusion

Monika Krampert stands out as a leading inventor in the field of therapeutic compositions, with a strong portfolio of patents that address significant medical challenges. Her innovative work continues to pave the way for advancements in treatment methodologies.